Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,465.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 1,540.00p
  • 52 Week Low: 736.00p
  • Currency: UK Pounds
  • Shares Issued: 48.90m
  • Volume: 25,330
  • Market Cap: £716.44m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
58.73% above the market average58.73% above the market average58.73% above the market average58.73% above the market average58.73% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
1yr Revenue Growth
68.18% above the market average68.18% above the market average68.18% above the market average68.18% above the market average68.18% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
16.77% above the market average16.77% above the market average16.77% above the market average16.77% above the market average16.77% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Book Ratio
90.21% below the market average90.21% below the market average90.21% below the market average90.21% below the market average90.21% below the market average
61.7% below the sector average61.7% below the sector average61.7% below the sector average61.7% below the sector average61.7% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
66.20% above the market average66.20% above the market average66.20% above the market average66.20% above the market average66.20% above the market average
50.82% above the sector average50.82% above the sector average50.82% above the sector average50.82% above the sector average50.82% above the sector average
Price Chg 3m
87.50% above the market average87.50% above the market average87.50% above the market average87.50% above the market average87.50% above the market average
80.33% above the sector average80.33% above the sector average80.33% above the sector average80.33% above the sector average80.33% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
35.06% above the market average35.06% above the market average35.06% above the market average35.06% above the market average35.06% above the market average
28.81% above the sector average28.81% above the sector average28.81% above the sector average28.81% above the sector average28.81% above the sector average
Momentum 20
66.76% above the market average66.76% above the market average66.76% above the market average66.76% above the market average66.76% above the market average
52.54% above the sector average52.54% above the sector average52.54% above the sector average52.54% above the sector average52.54% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
32.65% above the market average32.65% above the market average32.65% above the market average32.65% above the market average32.65% above the market average
58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average
ROCE
74.16% above the market average74.16% above the market average74.16% above the market average74.16% above the market average74.16% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
69.15% above the market average69.15% above the market average69.15% above the market average69.15% above the market average69.15% above the market average
74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average
Forecast EPS
33.88% above the market average33.88% above the market average33.88% above the market average33.88% above the market average33.88% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
26.77% above the market average26.77% above the market average26.77% above the market average26.77% above the market average26.77% above the market average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average
Operating Profit Loss
47.35% above the market average47.35% above the market average47.35% above the market average47.35% above the market average47.35% above the market average
67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
19.08% above the market average19.08% above the market average19.08% above the market average19.08% above the market average19.08% above the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Cash
20.05% above the market average20.05% above the market average20.05% above the market average20.05% above the market average20.05% above the market average
26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
86.12% above the market average86.12% above the market average86.12% above the market average86.12% above the market average86.12% above the market average
88.24% above the sector average88.24% above the sector average88.24% above the sector average88.24% above the sector average88.24% above the sector average
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
38.99% above the market average38.99% above the market average38.99% above the market average38.99% above the market average38.99% above the market average
10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 1,465.00p
Change Today -10.00p
% Change -0.68 %
52 Week High 1,540.00p
52 Week Low 736.00p
Volume 25,330
Shares Issued 48.90m
Market Cap £716.44m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.08% below the market average97.08% below the market average97.08% below the market average97.08% below the market average97.08% below the market average
91.84% below the sector average91.84% below the sector average91.84% below the sector average91.84% below the sector average91.84% below the sector average
Price Trend
93.26% above the market average93.26% above the market average93.26% above the market average93.26% above the market average93.26% above the market average
77.05% above the sector average77.05% above the sector average77.05% above the sector average77.05% above the sector average77.05% above the sector average
Income Not Available
Growth
90.73% above the market average90.73% above the market average90.73% above the market average90.73% above the market average90.73% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 21-Oct-2021

Time Volume / Share Price
16:35 1,478 @ 1,465.00p
16:29 5 @ 1,480.00p
16:29 49 @ 1,480.00p
16:29 7 @ 1,480.00p
16:29 7 @ 1,480.00p

Ergomed Key Personnel

CFO Richard Barfield

Top of Page